Nasdaq
$0.5580▲ 2.46%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.9MShares out 5.3M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
21- 5d agoRegular26.10.20 01:28PRE 14AOther#●●●#●●●#●●●
Co-Diagnostics, Inc.
Co-Diagnostics will hold a court-ordered special meeting of shareholders to vote on proposals including the election of directors, approval of an equity incentive plan, a reverse stock split (1:2 to 1:750 ratio), and Nasdaq compliance for warrant exercises and convertible note issuances. The company is also seeking approval to amend its articles of incorporation to set the quorum for shareholder meetings at one-third of the outstanding shares.…more
$0.5580+2.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.15After-hours26.10.16 05:158-KKey event
Co-Diagnostics, Inc.
Co-Diagnostics failed to transact business at its reconvened annual meeting on October 14, 2026, due to a lack of a quorum. The company decided not to adjourn the meeting further and intends to seek stockholder approval for the proposed matters at a future special meeting.…more
$0.5580+2.46%vs prev closeView filingShare - 10.15Pre-market26.10.15 19:108-K/AKey event
Co-Diagnostics, Inc.
Co-Diagnostics has secured up to $3.1 million in funding through the issuance of senior secured convertible promissory notes to J.J. Astor & Co. Under the agreement, all net proceeds from the company's existing at-the-market (ATM) offering program must be remitted to a controlled account for debt repayment and working capital. The company also issued 600,000 commitment shares to the lender, with further share issuances possible subject to shareholder approval.…more
$0.5580+2.46%vs prev closeView filingShare
20 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.6Pre-market26.10.06 22:11#●●●
Co-Diagnostics to Showcase PCR Platform and MTB Test at WHX Labs
Co-Diagnostics announced its participation in the upcoming WHX Labs event in South Africa to demonstrate its molecular diagnostic platform and tuberculosis test. As this is a promotional event without immediate financial impact or contract announcements, the market impact remains neutral.…more
$0.5580+2.46%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.15After-hours26.09.16 05:10
●●●●●●●● ●●●●● ●●●●●●
Co-Diagnostics has signed a material transfer agreement with ReadyGo Diagnostics to evaluate the compatibility of sample preparation technologies with its Co-Dx PCR platform. This agreement is strictly for preliminary feasibility studies and does not obligate either party to enter into further commercial arrangements.…more
$0.5580+2.46%vs prev closeShareBenzinga - 9.8Overnight26.09.08 16:11
●●●●●●●● ●●●●● ●●●●●●
Investors are monitoring upcoming earnings reports from companies like United Natural Foods and ABM Industries while reacting to Novartis's failed phase III clinical trial. Market participants are also tracking executive changes at Co-Diagnostics ahead of the Tuesday trading session.…more
$0.5580+2.46%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report